AG˹ٷ

STOCK TITAN

[144] Arrowhead Research Corporation SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Form 144 filed for ARWR reports a proposed sale of 611 common shares through Merrill Lynch on the NASDAQ with an aggregate market value of $12,190.05 and 138,257,550 shares outstanding. The notice specifies an approximate sale date of 08/13/2025.

The filing lists the acquisition history for the shares being sold: grants received as compensation on 01/04/2022 (3,485), 01/02/2023 (15,802), 01/04/2023 (12,557), 01/04/2024 (1,167), 01/08/2024 (4,950) and 01/04/2025 (27,271), with the named transferor in those records shown as James Hamilton. The form indicates no securities sold in the past three months and includes the required representation that the seller does not possess undisclosed material information.

Il Modulo 144 presentato per ARWR segnala una proposta di vendita di 611 azioni ordinarie tramite Merrill Lynch sul NASDAQ, con un valore di mercato complessivo di $12,190.05 e 138,257,550 azioni in circolazione. L'avviso indica una data di vendita approssimativa del 08/13/2025.

La dichiarazione riporta la cronologia delle acquisizioni delle azioni oggetto della vendita: assegnazioni ricevute come compenso in data 01/04/2022 (3,485), 01/02/2023 (15,802), 01/04/2023 (12,557), 01/04/2024 (1,167), 01/08/2024 (4,950) e 01/04/2025 (27,271), con il trasferente indicato in tali registri come James Hamilton. Il modulo indica che non sono stati venduti titoli nei tre mesi precedenti e include la dichiarazione richiesta che il venditore non è in possesso di informazioni materiali non divulgate.

El Formulario 144 presentado para ARWR informa una propuesta de venta de 611 acciones ordinarias a través de Merrill Lynch en el NASDAQ, con un valor de mercado agregado de $12,190.05 y 138,257,550 acciones en circulación. El aviso especifica una fecha aproximada de venta del 08/13/2025.

La presentación enumera el historial de adquisición de las acciones objeto de la venta: adjudicaciones recibidas como dzԲó el 01/04/2022 (3,485), 01/02/2023 (15,802), 01/04/2023 (12,557), 01/04/2024 (1,167), 01/08/2024 (4,950) y 01/04/2025 (27,271), con el cedente nombrado en esos registros como James Hamilton. El formulario indica que no se vendieron valores en los últimos tres meses e incluye la declaración requerida de que el vendedor no posee información material no divulgada.

ARWR� 대� 제출� Form 144� 611주의 보통� 매각 예정� Merrill Lynch� 통해 NASDAQ에서 보고했으�, � 시가가 $12,190.05이고 발행주식수는 138,257,550주입니다. 통지서에� 대략적� 매도 예정일을 08/13/2025� 명시하고 있습니다.

신고서에� 매도 대� 주식� 취득 이력� 기재되어 있습니다: 보상으로 수령� 부� 내역은 01/04/2022 (3,485), 01/02/2023 (15,802), 01/04/2023 (12,557), 01/04/2024 (1,167), 01/08/2024 (4,950) � 01/04/2025 (27,271)이며, 해당 기록� 기재� 양도인은 James Hamilton으로 표시되어 있습니다. 양식에는 또한 과거 3개월 동안 매도� 증권� 없다� 기재되어 있으�, 판매자가 미공� 중대� 정보� 보유하고 있지 않다� 필수 진술� 포함되어 있습니다.

Le formulaire 144 déposé pour ARWR signale une proposition de vente de 611 actions ordinaires via Merrill Lynch sur le NASDAQ, pour une valeur marchande totale de $12,190.05 et 138,257,550 actions en circulation. L'avis précise une date approximative de vente au 08/13/2025.

Le dépôt énumère l'historique d'acquisition des actions vendues : attributions reçues en tant que éܲéپDz le 01/04/2022 (3,485), 01/02/2023 (15,802), 01/04/2023 (12,557), 01/04/2024 (1,167), 01/08/2024 (4,950) et 01/04/2025 (27,271), le cédant inscrit dans ces registres étant James Hamilton. Le formulaire indique aucune vente de titres au cours des trois derniers mois et contient la déclaration requise selon laquelle le vendeur ne détient pas d'informations matérielles non divulguées.

Für ARWR eingereichtes Formular 144 meldet einen geplanten Verkauf von 611 Stammaktien über Merrill Lynch an der NASDAQ mit einem Gesamtmarktwert von $12,190.05 und 138,257,550 ausstehenden Aktien. Die Mitteilung nennt ein ungefähres Verkaufsdatum: 08/13/2025.

Die Einreichung listet die Erwerbshistorie der zu verkaufenden Aktien auf: Zuteilungen, erhalten als ձüٳܲԲ am 01/04/2022 (3,485), 01/02/2023 (15,802), 01/04/2023 (12,557), 01/04/2024 (1,167), 01/08/2024 (4,950) und 01/04/2025 (27,271), wobei der in diesen Unterlagen genannte Überträger als James Hamilton aufgeführt ist. Das Formular gibt an, dass in den letzten drei Monaten keine Wertpapiere verkauft wurden, und enthält die erforderliche Erklärung, dass der Verkäufer über keine nicht offengelegten wesentlichen Informationen verfügt.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Small proposed sale disclosed; details show shares were received as compensation over multiple years.

The filing documents a proposed sale of 611 common shares via Merrill Lynch on NASDAQ with an aggregate market value of $12,190.05 and outstanding shares of 138,257,550. The seller's acquisition history is fully listed and characterized as compensation from James Hamilton on specific dates from 2022�2025. The notice also records that no other securities were sold in the prior three months and includes the standard representation regarding material nonpublic information. For investors, this is a routine insider sale disclosure rather than a corporate operational update.

TL;DR: Compliance-focused disclosure showing insider-originated compensation shares and a planned brokered sale.

The Form 144 supplies the regulatory detail necessary for a proposed sale: broker name (Merrill Lynch), exchange (NASDAQ), number of shares (611), aggregate market value ($12,190.05) and the acquisition trail for those shares labeled as compensation with James Hamilton identified as the source across multiple dates. The filing also asserts the signer is unaware of undisclosed material adverse information. This presentation aligns with routine governance and disclosure expectations for executive or insider sales.

Il Modulo 144 presentato per ARWR segnala una proposta di vendita di 611 azioni ordinarie tramite Merrill Lynch sul NASDAQ, con un valore di mercato complessivo di $12,190.05 e 138,257,550 azioni in circolazione. L'avviso indica una data di vendita approssimativa del 08/13/2025.

La dichiarazione riporta la cronologia delle acquisizioni delle azioni oggetto della vendita: assegnazioni ricevute come compenso in data 01/04/2022 (3,485), 01/02/2023 (15,802), 01/04/2023 (12,557), 01/04/2024 (1,167), 01/08/2024 (4,950) e 01/04/2025 (27,271), con il trasferente indicato in tali registri come James Hamilton. Il modulo indica che non sono stati venduti titoli nei tre mesi precedenti e include la dichiarazione richiesta che il venditore non è in possesso di informazioni materiali non divulgate.

El Formulario 144 presentado para ARWR informa una propuesta de venta de 611 acciones ordinarias a través de Merrill Lynch en el NASDAQ, con un valor de mercado agregado de $12,190.05 y 138,257,550 acciones en circulación. El aviso especifica una fecha aproximada de venta del 08/13/2025.

La presentación enumera el historial de adquisición de las acciones objeto de la venta: adjudicaciones recibidas como dzԲó el 01/04/2022 (3,485), 01/02/2023 (15,802), 01/04/2023 (12,557), 01/04/2024 (1,167), 01/08/2024 (4,950) y 01/04/2025 (27,271), con el cedente nombrado en esos registros como James Hamilton. El formulario indica que no se vendieron valores en los últimos tres meses e incluye la declaración requerida de que el vendedor no posee información material no divulgada.

ARWR� 대� 제출� Form 144� 611주의 보통� 매각 예정� Merrill Lynch� 통해 NASDAQ에서 보고했으�, � 시가가 $12,190.05이고 발행주식수는 138,257,550주입니다. 통지서에� 대략적� 매도 예정일을 08/13/2025� 명시하고 있습니다.

신고서에� 매도 대� 주식� 취득 이력� 기재되어 있습니다: 보상으로 수령� 부� 내역은 01/04/2022 (3,485), 01/02/2023 (15,802), 01/04/2023 (12,557), 01/04/2024 (1,167), 01/08/2024 (4,950) � 01/04/2025 (27,271)이며, 해당 기록� 기재� 양도인은 James Hamilton으로 표시되어 있습니다. 양식에는 또한 과거 3개월 동안 매도� 증권� 없다� 기재되어 있으�, 판매자가 미공� 중대� 정보� 보유하고 있지 않다� 필수 진술� 포함되어 있습니다.

Le formulaire 144 déposé pour ARWR signale une proposition de vente de 611 actions ordinaires via Merrill Lynch sur le NASDAQ, pour une valeur marchande totale de $12,190.05 et 138,257,550 actions en circulation. L'avis précise une date approximative de vente au 08/13/2025.

Le dépôt énumère l'historique d'acquisition des actions vendues : attributions reçues en tant que éܲéپDz le 01/04/2022 (3,485), 01/02/2023 (15,802), 01/04/2023 (12,557), 01/04/2024 (1,167), 01/08/2024 (4,950) et 01/04/2025 (27,271), le cédant inscrit dans ces registres étant James Hamilton. Le formulaire indique aucune vente de titres au cours des trois derniers mois et contient la déclaration requise selon laquelle le vendeur ne détient pas d'informations matérielles non divulguées.

Für ARWR eingereichtes Formular 144 meldet einen geplanten Verkauf von 611 Stammaktien über Merrill Lynch an der NASDAQ mit einem Gesamtmarktwert von $12,190.05 und 138,257,550 ausstehenden Aktien. Die Mitteilung nennt ein ungefähres Verkaufsdatum: 08/13/2025.

Die Einreichung listet die Erwerbshistorie der zu verkaufenden Aktien auf: Zuteilungen, erhalten als ձüٳܲԲ am 01/04/2022 (3,485), 01/02/2023 (15,802), 01/04/2023 (12,557), 01/04/2024 (1,167), 01/08/2024 (4,950) und 01/04/2025 (27,271), wobei der in diesen Unterlagen genannte Überträger als James Hamilton aufgeführt ist. Das Formular gibt an, dass in den letzten drei Monaten keine Wertpapiere verkauft wurden, und enthält die erforderliche Erklärung, dass der Verkäufer über keine nicht offengelegten wesentlichen Informationen verfügt.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the ARWR Form 144 disclose?

The notice discloses a proposed sale of 611 common shares via Merrill Lynch on NASDAQ with an aggregate market value of $12,190.05 and 138,257,550 shares outstanding.

When is the approximate sale date listed on the ARWR Form 144?

The filing lists the approximate date of sale as 08/13/2025.

How were the shares being sold acquired according to the filing?

The shares were acquired as compensation on multiple dates: 01/04/2022 (3,485), 01/02/2023 (15,802), 01/04/2023 (12,557), 01/04/2024 (1,167), 01/08/2024 (4,950), and 01/04/2025 (27,271).

Who is named in the filing as the source of the acquired shares?

The acquisition table names James Hamilton as the person from whom the compensation shares were listed as acquired.

Does the filing report any securities sold by the person in the past three months?

No. The filing's section on sales during the past three months states Nothing to Report.
Arrowhead Pharma

NASDAQ:ARWR

ARWR Rankings

ARWR Latest News

ARWR Latest SEC Filings

ARWR Stock Data

2.38B
120.27M
13.02%
78.91%
8.99%
Biotechnology
Pharmaceutical Preparations
United States
PASADENA